Replies to post #106651 on Biotech Values

[DewDiligence]

Quiz (low difficulty)—The EU rubber-stamped Pradaxa today for AF/stroke prevention. What did the EU do differently from the FDA with respect to Pradaxa in this indication?

[DewDiligence]

Pradaxa—the oral anticoagulant from Boehringer-Ingelheim—is now selling at an annualized rate of more than $1B:

http://online.wsj.com/article/BT-CO-20120424-703015.html

Pradaxa was: approved in the EU for VTE prevention in 2008 (#msg-27956748), approved in the US for AF/stroke prevention in 2010 (#msg-55725156); and approved in the EU for AF/stroke prevention in 2011 (#msg-65889172). (B-I never submitted Pradaxa for approval for VTE prevention in the US.)